Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:DRH
NasdaqGS:DRHHotel and Resort REITs

A Look At DiamondRock Hospitality (DRH) Valuation After Fresh Zacks Buy Rating And Earnings Outlook

Analyst coverage from Zacks has put fresh attention on DiamondRock Hospitality (DRH), as the firm reiterates a favorable earnings outlook and Buy ranking, highlighting earnings estimate revisions and valuation metrics versus hotel focused REIT peers. See our latest analysis for DiamondRock Hospitality. The latest Zacks commentary comes as DiamondRock Hospitality’s share price sits at US$9.76, with a 90 day share price return of 6.55% and a 1 year total shareholder return of 39.96%. This may...
NYSE:CI
NYSE:CIHealthcare

Cigna Revenue Grows As Shrinking Customer Base Raises Competitive Questions

Cigna Group, NYSE:CI, is reporting steady revenue growth alongside a significant decline in its customer base over the past two years. This combination suggests product and competitive pressures that are starting to reshape how the company earns its revenue. The shift in customer numbers is becoming a key issue for investors tracking Cigna's long term position in health benefits and related services. Cigna Group, NYSE:CI, recently closed at $277.56, with the share price up 3.8% over the...
SEHK:3690
SEHK:3690Hospitality

Meituan (SEHK:3690) Valuation Check As Higher Sales Coincide With Swing To Net Loss

Meituan (SEHK:3690) is back in focus after its latest earnings release, where higher fourth quarter and full year sales were reported alongside a shift from prior net income to sizeable losses. See our latest analysis for Meituan. The latest results arrived after a mixed run in the stock, with a 7 day share price return of 9.66% and a 30 day share price return of 11.25%. However, the year to date share price return was negative 15.87% and the 1 year total shareholder return was negative...
ENXTAM:HEIA
ENXTAM:HEIABeverage

Is It Time To Reassess Heineken (ENXTAM:HEIA) After Recent Share Price Weakness

If you are wondering whether Heineken at around €69.08 is a fair deal or a stretch, this breakdown will help you make sense of what the current share price might be implying. The stock has returned 2.2% over the last 7 days, while the 1 year return sits at a slight decline of 0.3% and the 3 year return shows a larger 26.8% decline, which may shape how you think about both risk and potential upside. Recent coverage has focused on Heineken's position in the global beverages market and how...
TSE:5932
TSE:5932Building

Sankyo Tateyama (TSE:5932) Returns To Q3 Profit Challenging Persistent Loss Narratives

Sankyo Tateyama (TSE:5932) has posted its Q3 2026 numbers with revenue of ¥84,213 million and basic EPS of ¥2.33, alongside net income of ¥73 million that contrasts with prior quarterly losses in the trailing figures. Over recent quarters, revenue has ranged between ¥84,043 million and ¥93,713 million while basic EPS has swung from a loss of ¥61.37 to a small profit of ¥0.35 before Q3, giving a picture of a business where the top line has been relatively steady but earnings have been more...
NYSE:AXP
NYSE:AXPConsumer Finance

Is It Too Late To Consider American Express (AXP) After Its Strong Multi‑Year Rally

Wondering if American Express at around US$316 per share is still offering value or if the easy gains are behind it? This breakdown is designed to help you weigh that up with a clear focus on price versus fundamentals. The stock has returned 4.9% over the last 7 days and 3.6% over the last 30 days, while the year-to-date return is a 15.1% decline, compared with a 21.8% return over the last year and 105.8% and 128.0% over the last 3 and 5 years respectively. Recent attention on American...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Assessing Travere Therapeutics (TVTX) Valuation After FDA Extends Filspari Review To April 2026

FDA review extension puts spotlight on Travere Therapeutics The latest move in Travere Therapeutics (TVTX) comes after the FDA extended its review of the supplemental New Drug Application for Filspari. The agency set a new April 2026 action date that reshapes the timeline investors are watching. See our latest analysis for Travere Therapeutics. Travere’s share price has reacted quickly to the FDA update, with a recent 9.5% jump and a 10.65% 1 month share price return. However, the year to...
NYSE:RNR
NYSE:RNRInsurance

Is It Too Late To Consider RenaissanceRe Holdings (RNR) After Strong Multi‑Year Share Price Gains?

If you are wondering whether RenaissanceRe Holdings at around US$307 per share still offers value, or if most of the upside is already reflected in the price, this article breaks that question down for you. The stock has recent returns of 3.9% over 7 days, 3.5% over 30 days, 12.8% year to date, 29.3% over 1 year, 51.3% over 3 years and 86.3% over 5 years. These figures naturally raise questions about what is already priced in. Recent news coverage has focused on RenaissanceRe Holdings as a...
NYSE:PII
NYSE:PIILeisure

Polaris (PII) Valuation Check As Citi Cuts Price Target And Q1 Retail Trends Surprise

Citi’s recent cut to its Polaris (PII) price target, tied to higher macro uncertainty, came just as Q1 North America off road retail units were slightly ahead of management’s earlier expectations. See our latest analysis for Polaris. At a share price of $55.38, Polaris has seen a 5.03% 30 day share price return after a sharp 24.76% share price decline over 90 days. The 1 year total shareholder return of 58.81% contrasts with weak 3 and 5 year total shareholder returns. If this kind of reset...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Freshpet (FRPT) Valuation Check After Recent 21.5% Share Price Slide

Wondering if Freshpet at around US$65 per share is priced for opportunity or already reflects its prospects? This article walks through what the current valuation really suggests. The stock recently closed at US$65.03, with a 7 day return of 8.2%, a 30 day return decline of 21.5%, and a 1 year return decline of 21.5%. This makes the recent move particularly important to put in context. Over a longer stretch, Freshpet has a year to date return of 8.1%, a 3 year return of 2.8%, and a 5 year...
TSX:RY
TSX:RYBanks

Is RBC’s Expanded ETFs and Avion Platform Deepening Its Moat for Investors in TSX:RY?

In recent weeks, Royal Bank of Canada has broadened its product lineup by launching new RBC iShares target-maturity bond ETFs and actively managed equity ETFs, while also enhancing its Avion Rewards travel platform through a collaboration with Hopper Technology Solutions. Together, these moves highlight RBC’s focus on deepening customer engagement across both investment and credit card ecosystems, tying loyalty, travel and ETF offerings more tightly into its core banking and wealth...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Is Visteon (VC) Still Attractive After A 33% One Year Share Price Gain

If you are wondering whether Visteon at around US$97 per share is still offering value, it helps to look past the headline price and focus on what the current valuation is really telling you. The stock has returned 4.7% over the last 7 days, 5.7% over 30 days, 0.1% year to date and 32.7% over the past year. The 3 year and 5 year returns of 33.7% and 17.9% highlight that the longer term experience has been more mixed. Recent coverage of Visteon has focused on its position in the auto...
NYSE:NOW
NYSE:NOWSoftware

Does ServiceNow’s (NOW) DXC ‘Customer Zero’ Deal Quietly Redefine Its AI Platform Strategy?

In early April 2026, DXC Technology announced a new multi-year agreement with ServiceNow to act as Customer Zero for ServiceNow’s Core Business Suite, deploying agentic AI across its Global Business Services model to modernize complex, multivendor enterprise operations. This move effectively turns DXC into a large-scale proving ground for ServiceNow’s AI platform, generating validated, reusable automation blueprints and industry use cases that can be rolled out to other enterprises. Next,...
TSE:2659
TSE:2659Consumer Retailing

SAN Altech TTM Margin Slip To 4.3% Tests Bullish Quality Earnings Narrative

Sankyo Altech (TSE:2659) has wrapped up FY 2026 with fourth quarter revenue of ¥78,029 million and basic EPS of ¥42.06, while trailing 12 month revenue stands at ¥245,547 million with EPS of ¥172.66 as investors weigh these outcomes against a current share price of ¥3,355. Over recent periods the company has reported quarterly revenue in a range from ¥54,358 million to ¥78,029 million, with basic EPS between ¥35.62 and ¥53.74 against a trailing 12 month net income of ¥10,678 million, offering...
NYSE:IOT
NYSE:IOTSoftware

Can Samsara (IOT) Turn Its AI Data Platform Into Durable Operating Margin Strength?

Samsara recently reported a fourth-quarter earnings beat and constructive fiscal 2027 outlook, highlighting progress toward 19% operating margins and scalable growth. Management emphasized the role of its large AI-enabled data platform as a key driver of future operational efficiency and safety solutions for customers. We’ll now explore how this stronger margin outlook and AI-enabled platform shape Samsara’s investment narrative for long-term-oriented investors. This technology could replace...
ENXTAM:INGA
ENXTAM:INGABanks

Is It Too Late To Consider ING Groep (ENXTAM:INGA) After A 71% One Year Rally?

Investors may be wondering if ING Groep at €24.20 is still offering value after a strong run, or if most of the easy gains are already on the table. The stock has returned 4.2% over the last 7 days and 7.3% over the last 30 days, with a 1 year return of 71.3%, 3 year return of 159.0% and 5 year return of 226.2%. The year to date return currently stands at a 1.2% decline. Recent coverage has focused on ING Groep's share price strength over the past year and how it compares with the broader...
TSX:ARE
TSX:AREConstruction

Did Aecon’s Discounted Equity Raise and Insider Sale Just Shift Aecon Group's (TSX:ARE) Investment Narrative?

Aecon Group Inc. recently completed a follow-on equity offering of CA$150.01 million, issuing 3,822,000 common shares at CA$39.25 each, while Director Eric Stuart Rosenfeld, on behalf of Crescendo Partners III, L.P., sold 125,000 shares on March 27, 2026, sharply reducing that account’s holdings. The combination of fresh capital raised at a discount and a large insider sale raises questions about ownership dilution, capital deployment priorities, and insider confidence that many investors...
TSXV:SNM
TSXV:SNMOil and Gas

Exploring 3 Undervalued Small Caps With Insider Action In Global Markets

As global markets navigate the complexities of Middle East tensions and energy market volatility, small-cap stocks have shown resilience with notable gains in indexes like the S&P MidCap 400 and Russell 2000. Amidst this backdrop, identifying undervalued small-cap stocks with insider action can be a strategic approach for investors looking to capitalize on potential growth opportunities in an uncertain economic environment.
SHSE:688522
SHSE:688522Electronic

Exploring Three High Growth Tech Stocks in Global Markets

In recent weeks, global markets have experienced significant volatility due to geopolitical tensions in the Middle East and fluctuating energy prices, with major indices like the Nasdaq Composite and S&P 500 showing notable gains amid easing inflation concerns. As investors navigate these dynamic conditions, identifying high-growth tech stocks that demonstrate resilience and innovation can be crucial for capitalizing on potential opportunities in an ever-evolving market landscape.
TSE:5801
TSE:5801Electrical

3 Global Stocks That Might Be Undervalued By Up To 45.1%

In the midst of geopolitical tensions and fluctuating energy markets, global indices have experienced notable volatility, with major U.S. stock indexes posting gains amid hopes for de-escalation in the Middle East. As investors navigate these uncertain times, identifying undervalued stocks can be a strategic approach to potentially capitalize on market inefficiencies and position portfolios for long-term growth.
SHSE:603920
SHSE:603920Electronic

Global Growth Companies With High Insider Ownership

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite and S&P 500 have shown resilience with notable gains. In this environment, growth companies with high insider ownership can be particularly appealing, as they often demonstrate strong alignment between management and shareholder interests, potentially offering stability amidst geopolitical uncertainties.
SZSE:300145
SZSE:300145Machinery

Discover Global Penny Stocks: Zhongzhu Healthcare HoldingLtd Leads Our Trio

Global markets have been navigating a complex landscape, with recent geopolitical tensions and energy market volatility influencing investor sentiment. Against this backdrop, penny stocks emerge as intriguing opportunities for investors seeking growth potential at lower price points. Although the term "penny stocks" may seem outdated, these smaller or newer companies can offer substantial value when supported by strong financials and clear growth prospects.
TSE:6278
TSE:6278Machinery

Undiscovered Gems in Global Markets for April 2026

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite and S&P 500 have shown resilience with notable gains. Amid these broader market movements, smaller-cap stocks are also capturing attention, buoyed by positive employment data and easing inflation concerns. In such a dynamic environment, identifying promising small-cap stocks often involves looking for companies with strong fundamentals that can thrive...